Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:995-997
doi: 10.1161/CIRCRESAHA.108.176172
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bridge, J. H.B.
Right arrow Articles by Savio-Galimberti, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bridge, J. H.B.
Right arrow Articles by Savio-Galimberti, E.
(Circulation Research. 2008;102:995.)
© 2008 American Heart Association, Inc.


Editorials

What Are the Consequences of Phosphorylation and Hyperphosphorylation of Ryanodine Receptors in Normal and Failing Heart?

John H.B. Bridge, Eleonora Savio-Galimberti

From the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City.

Correspondence to John Bridge, PhD, University of Utah, CVRTI, 95 South 2000 East, Salt Lake City, Utah 84112-5000.



See related article, pages e65–e72


Key Words: hyperphosphorylation • adrenergic


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Marks and colleagues published some influential results in 2000, suggesting that protein kinase A phosphorylation regulates ryanodine receptor (RyR2) open probability (PoRyR). The authors attributed this to the dissociation of the RyR-associated regulatory protein FKBP12.6.1 They went on to propose that, in failing hearts, RyR2 is hyperphosphorylated, which leads to defective channel function by increasing sensitivity to Ca-induced activation of the molecule. Moreover, these effects were attributable to phosphorylation of a single amino acid, serine 2809 (S2809). There are 4 of these serine molecules at location 2808 in the human RyR2 molecule, 1 on each subunit of the tetramer. Much subsequent work has referred to the 2809 residue, which is found in rabbits. Marks and colleagues further suggested that phosphorylation of S2809 was also responsible for the normal effects of adrenergic stimulation on excitation–contraction coupling (ECC) and that hyperphosphorylation was responsible for abnormal ECC during failure.

The RyR is a tetramer that forms the largest membrane ion channel. In muscle, it is found in the sarcoplasmic reticulum (SR), where it functions as the Ca release channel. The heart isoform is designated RyR2. The pore sequences are largely found in membrane spanning domains.2 There is a large cytosolic domain. Although hyperphosphorylation refers, by definition, to the occupation of all the putative phosphorylation sites in a molecule in the context of the work by Marks and colleagues,1 hyperphosphorylation refers to 3 or perhaps 4 of the serine residues. In RyRs, there are a large number of consensus phosphorylation sites.3 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ. Res.Home page
D. Terentyev, A. E. Belevych, R. Terentyeva, M. M. Martin, G. E. Malana, D. E. Kuhn, M. Abdellatif, D. S. Feldman, T. S. Elton, and S. Gyorke
miR-1 Overexpression Enhances Ca2+ Release and Promotes Cardiac Arrhythmogenesis by Targeting PP2A Regulatory Subunit B56{alpha} and Causing CaMKII-Dependent Hyperphosphorylation of RyR2
Circ. Res., February 27, 2009; 104(4): 514 - 521.
[Abstract] [Full Text] [PDF]